Brief: Cancer Genetics Reports First Quarter 2020 Financial Results

Vyant Bio

24/06/2020 22:41

June 24 (Reuters) - Cancer Genetics Inc  CGIX.O :
    * CANCER GENETICS REPORTS FIRST QUARTER 2020 FINANCIAL
RESULTS AND
PROVIDES STRATEGIC BUSINESS UPDATES
    * Q1 LOSS PER SHARE $0.56 FROM CONTINUING OPERATIONS
    * Q1 REVENUE $1.4 MILLION VERSUS $1.8 MILLION
    * EXPECT OPERATING COSTS TO BE SIGNIFICANTLY REDUCED IN
SECOND
HALF OF 2020

Source text for Eikon:  ID:nGNX979tYF 
Further company coverage:  CGIX.O 

 ((Briefs@thomsonreuters.com;))